LAVA Therapeutics N.V. (LVTX)
1.740
0.00 (0.00%)
Inactive · Last trade price on Nov 20, 2025
LAVA Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for LAVA Therapeutics stock had an average target of $1.58, with a low estimate of $1.24 and a high estimate of $2.00.
Price Target: $1.58 (-9.20%)
Analyst Consensus: Hold
Price Target
Analyst Ratings
The average analyst rating for LAVA Therapeutics stock from 4 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.
Recommendation Trends
No data available
| Rating | Oct 2026 |
|---|---|
| Strong Buy | n/a |
| Buy | n/a |
| Hold | n/a |
| Sell | n/a |
| Strong Sell | n/a |
| Total | n/a |
Financial Forecast
Revenue This Year
n/a
from 11.98M
Revenue Next Year
n/a
EPS This Year
-0.86
from -0.94
EPS Next Year
-0.51
from -0.86
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.88 | -0.49 | |||
| Avg | -0.86 | -0.51 | |||
| Low | -0.82 | -0.52 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |